🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Completed
Location
Fox Chase - Temple Cancer Center
Start Date
1993-02
Trial ID
NCT00002521
Therapy related acute myeloid leukemia and myelodysplasia (t-MN) is a poten...
Status
Recruiting
Location
Istituto Europeo di Oncologia
Start Date
2020-10-02
Trial ID
NCT06785077
Treatments Being Tested
The goal of this clinical research trial is to study the use of differing i...
Status
Recruiting
Location
The New York Proton Center
Start Date
2022-01-24
Trial ID
NCT05313191
Treatments Being Tested
RATIONALE: Biological therapies such as hu14.18-interleukin-2 fusion protei...
Status
Completed
Location
Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham
Start Date
2005-08
Trial ID
NCT00082758
Treatments Being Tested
A prospective Phase II clinical study to assess the efficacy and toxicity o...
Status
Completed
Location
HELIOS Klinik Berlin-Buch, Klinik für Hämatologie und Stammzelltransplantation
Start Date
2019-06-24
Trial ID
NCT04121507
This phase I trial studies the side effects and best dose of nivolumab when...
Status
Terminated
Location
UC San Diego Moores Cancer Center
Start Date
2015-10-21
Trial ID
NCT02408861
To safely reduce the burden of therapy in children, adolescents and young a...
Status
Completed
Location
Roswell Park Cancer Institute
Start Date
2013-01
Trial ID
NCT01859819
Treatments Being Tested
The purpose of this study is to determine the safety of and to select a tre...
Status
Completed
Location
UCLA School of Medicine Hematology/Oncology
Start Date
2007-04-01
Trial ID
NCT00463385
Treatments Being Tested
This phase II trial is studying how well hu14.18-interleukin-2 (IL2) fusion...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2011-09
Trial ID
NCT01334515
Treatments Being Tested
The purpose of this study is to find out if an antibody called Humanized 3F...
Status
Active Not Recruiting
Location
Memorial Sloan Kettering Cancer Center
Start Date
2012-12
Trial ID
NCT01757626
Treatments Being Tested